The largest database of trusted experimental protocols

10 protocols using tgf β1

1

TGF-β1 Induced NOS2 Cell Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
NOS2 cells were stimulated with recombinant human transforming growth factor-β1 (TGF-β1) (Wako Pure Chemical Industries, Osaka, Japan) at 10 ng/ml in RPMI-1640 supplemented with 2% FBS for 96 h. After a 96-h incubation with TGF-β1, the cells were washed with PBS and used for a number of assays.
+ Open protocol
+ Expand
2

Collagen Synthesis in Lung Fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
Normal human adult lung fibroblasts (NHLF) (LONZA, Walkersville, MD, USA) were cultured in fibroblast basal medium (LONZA) supplemented with 2% fetal bovine serum (LONZA, Walkersville, MD, USA), human recombinant fibroblast growth factor (1.0 μg/mL), insulin (5 mg/mL), gentamicin, and amphotericin B at 37 °C in a humidified atmosphere with 5% CO2. Normal mouse lung fibroblasts (MLg) (ATCC, Manassas, VA, USA) were grown in RPMI 1640 (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% fetal bovine serum at 37 °C in a humidified atmosphere with 5% CO2. All experiments were performed after 3–5 cell passages.
For the collagen synthesis assay, we plated NHLF and MLg (2 × 105 cells) in 6-well plates, in a final volume of 2 mL. After 24 h, we stimulated NHLF and MLg with transforming growth factor beta 1 (TGF-β1; 5 ng/mL) (WAKO, Osaka, Japan) and HSP47 inhibitor (5 μM, 10 μM, and 25 μM), dimethyl sulfoxide (DMSO; 5 μg/mL) (WAKO, Osaka, Japan) as a negative control. The cells were used to evaluate the effect of the HSP47 inhibitor on collagen synthesis by western blotting, MTT assay, and scratch test. All assays were repeated at least four times.
+ Open protocol
+ Expand
3

Osteogenic Differentiation of Human iPSCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
We previously reported an effective method for inducing osteogenesis in human iPSCs [21 (link),22 (link)]. Briefly, human iPSCs were incubated in the presence or absence of a SMO agonist or inhibitor in osteoblast differentiation medium (OBM). The OBM consisted of α-MEM (Invitrogen) supplemented with 10% FBS, 50 μg/ml L-ascorbic acid (Wako Pure Chemical Industries Ltd.), 10 mM β-glycerophosphate (Wako Pure Chemical Industries Ltd.), and 10 nM dexamethasone (Wako Pure Chemical Industries Ltd.). A combination of cytokines, referred to as FIT and comprising 25 ng/ml bFGF, 1 ng/ml TGF-β1 (Wako Pure Chemical Industries Ltd.), and 100 ng/ml IGF-1 (Wako Pure Chemical Industries Ltd.), was added on the following day (day 0). The iPSCs were cultured for an additional 10 days, with the OBM replenished every 3 days.
+ Open protocol
+ Expand
4

Cell Migration Assay with TGF-β1

Check if the same lab product or an alternative is used in the 5 most similar protocols
MIO-M1 cell migration was evaluated using an Oris 96-well cell migration assay kit (Platypus Technologies, Madison, WI), according to the manufacturer’s instructions. Cells were seeded in each well and transfected with siRNAs. After 1 hour of pretreatment with 1% FBS/DMEM containing 10 ng/ml TGF-β1 with 5 mM aphidicolin (Fuji Film Wako Pure Chemicals, Osaka, Japan) to inhibit cell division, the stoppers were removed to allow cells to migrate into the detection zone. The cells were then incubated for 48 hours and stained with PBS containing calcein AM (Dojindo, Kumamoto, Japan) for 1 hour. The signal intensity of the stained cells that migrated into the detection zone was measured with an Infinite F200 PRO microplate reader in the fluorescence mode (TECAN, Männedorf, Switzerland) using a fluorescence filter set (excitation, 485 nm; emission, 535 nm) with an Oris detection mask attached to the bottom of the plate.
+ Open protocol
+ Expand
5

Muse Cell Differentiation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Muse cells were plated at 1.55 × 104/cm2 and cultured in the adherent state for the entire period of induction on a laminin-coated surface. The cells were first incubated with DMEM low glucose containing 2% of FBS plus TGF-β1 (2.5 ng/mL, Wako), BMP-4 (5 ng/mL, Wako), BMP-2 (5 ng/mL, Sigma-Aldrich), activin A (10 ng/mL, Wako), Wnt-3a (50 ng/mL, R&D Systems, Minneapolis, MN, USA), and bFGF (10 ng/mL, Wako) for 7 d and then for 2 wk with DMEM low glucose containing 2% of FBS plus TGF-β1, insulin-like growth factor-1 (IGF-1, 5 ng/mL, Sigma-Aldrich), hepatocyte growth factor (HGF; 20 ng/mL, Wako), and cardiotrophin-1 (CT-1; 200 ng/mL, Sigma-Aldrich).
+ Open protocol
+ Expand
6

Cytokine-induced HEK293 and NHDF cell culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human embryonic kidney 293 (HEK293) (KAC Co, Ltd (Kyoto, Japan)) and HEK293T cells were cultured in Eagle’s minimum essential medium (FUJIFILM Wako Pure Chemical, Osaka, Japan) supplemented with 1 × nonessential amino acids (FUJIFILM Wako Pure Chemical) and 10% (v/v) fetal bovine serum (FBS). HEK293 cells were seeded at a density of 7.5 × 105 cells/well in a 24-well plate and incubated with or without IL-1β (1 ng/ml) and TGF-β1 (10 ng/ml) (FUJIFILM Wako Pure Chemical).
Normal human dermal fibroblasts (NHDFs), Detroit 551, were obtained from the American Type Culture Collection (VA, USA). The Detroit 551 cells were maintained in Eagle’s minimum essential medium supplemented with 1 × nonessential amino acids, 1 mM sodium pyruvate, and 10% (v/v) FBS. The Detroit 551 cells were seeded at a density of 2.5 × 104 cells/well in a 24-well plate and incubated with or without a mixture of the cytokines (0.1–1.0 ng/ml, TNF-α, IL-1β, and IL-6), IL-1β (1.0 ng/ml) or TGF-β (10 ng/ml) (FUJIFILM Wako Pure Chemical).
+ Open protocol
+ Expand
7

VASH2 Knockdown in DISS and SKOV3 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
DISS and SKOV3 cells and VASH2 knocked‐down (sh‐VASH2) clonal cell lines from DISS cells were described previously.21 Cells were maintained in DMEM (Wako, Saitama, Japan) with 10% FBS (Sigma‐Aldrich) and penicillin–streptomycin (Wako). For experimental treatments, the serum was reduced to 0.5% and 10 ng/mL TGF‐β1 (Wako) or 5 μM SB431542 (Wako) was added.
+ Open protocol
+ Expand
8

TGF-β1 and FGF2 Modulate EMT in RLE Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rat AEC2 cell line RLE-6TN (RLE) cells [48 (link)] were obtained from American Type Culture Collection (ATCC). RLE cells were cultured in Dulbecco’s-modified Eagle’s medium/Nutrient F-12 Ham (DMEM/F12) (Sigma) containing 10% FBS and subcultured every 2 d. To induce EMT, 1 104 cells/cm2 were cultured in DMEM/F12 containing 1% FBS for 24 h and then stimulated with 0.5 ng/ml recombinant human TGF-β1 (R&D Systems) dissolved in 4 mM HCl containing 0.1% bovine serum albumin for 48 h. To assess the effect of FGF2 on EMT, cells were stimulated with 0.5 ng/ml TGF-β1 and 10–100 ng/ml recombinant human FGF2 (Wako) with 100 μg/ml heparin. To analyze signaling pathways, cells were pretreated with 2–10 μM U0126 (Promega) or 10 μM LY294002 (Promega) for 30 min and then stimulated with 0.5 ng/ml TGF-β1 alone or in combination with 50 ng/ml FGF2.
+ Open protocol
+ Expand
9

Isolation and Culture of Rheumatoid Arthritis Synovial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
A total of 6 patients with RA diagnosed based on the revised 1987 American College of Rheumatology criteria for RA were recruited. Synovial tissues were collected from 6 patients who underwent arthroplastic joint surgery and synovectomy.
Synovia obtained from RA patients were aseptically dissected from the surrounding tissues, minced, and enzymatically digested with 2 mg/mL Clostridium collagenase (Wako Pure Chemical Industries, Ltd, Osaka, Japan) and 5-10 μg/mL deoxyribonuclease 1 (Sigma Chemical Co., St. Louis, MO, USA) for 2-3 h. After digestion, the resulting single cell suspension was washed, filtered through sterile gauze and nylon mesh, washed thoroughly again, and finally resuspended in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% heat-inactivated fetal calf serum. The cells were then cultured overnight to allow the cells to adhere to the culture plate. After washing the plate to remove nonadherent cells, the remaining adherent cells were cultured with the indicated cytokines, and adherent cells of 2-3 passages were further used in this study. The recombinant human cytokines used in this study were as follows: IL-1β, TNFα, IL-6, IL-6Rα, IL-17A, M-CSF (all BioLegend, San Diego, CA, USA), TGF-β 1 , activin A, and RANKL (all Wako Pure Chemical Industries).
+ Open protocol
+ Expand
10

Differentiation of TH1 and TH17 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
For the differentiation of TH1 cells35 (link), CD45.1+OT-II CD4+ T cells (2×105) were cultured with pDCs (2×104) in the presence or absence of IMQ (5 μg/ml) in combination with OVA323-339 peptide (1 μM), anti-IL-4 mAb (10 μg/ml; 11B11, BD Biosciences) and recombinant mouse IL-2 (0.2 ng/ml; Wako Pure Chemicals) for 3 days in 96-well flat-bottomed plates. For the differentiation of TH17 cells35 (link), CD45.1+OT-II CD4+ T cells (2×105) were cultured with pDCs (2×104) in the presence or absence of IMQ (5 μg/ml) in combination with OVA323–339 peptide (1 μM), anti-IFN-γ mAb (10 μg/ml; R4-6A2, BD Biosciences), anti-IL-4 mAb (10 μg/ml; 11B11), recombinant mouse IL-2 (0.2 ng/ml) and recombinant human transforming growth factor (TGF)-β1 (10 ng/ml; Wako Pure Chemicals) for 3 days in 96-well flat-bottomed plates. In some experiments, anti-IL-6 mAb (10 μg/ml; MP5-20F3, eBioscience), anti-IL-12 mAb (10 μg/ml; C17.8, eBioscience) or anti-IFNAR1 mAb (10 μg/ml; MAR1-5A3, eBioscience) was added to the culture. Analysis of the expression of IFN-γβ and/or IL-17 among gated CD4+ T cells was performed by flow cytometry as described above.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!